{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P05231",
      "entity_text" : "IL-6",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:59174488",
      "entity_text" : "Spebrutinib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Spebrutinib inhibited B-cell proliferation with an IC 50 of 0.7 muM; reduced expression of activation markers CD86, CD40, CD54, and CD69; and inhibited IL-6 production.",
  "reading_complete" : "2020-07-28T16:59:33Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T16:55:57Z",
  "trigger" : "inhibited",
  "evidence" : [ "Spebrutinib inhibited B-cell proliferation with an IC 50  of 0.7 muM; reduced expression of activation markers CD86, CD40, CD54, and CD69; and inhibited IL-6" ],
  "pmc_id" : "7021855",
  "score" : 0
}